fda glp-1 enforcement news october 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Key Takeaways | The GLP-1

After taking the Prime Health quiz, I have a lot to report back on - BMI requirements, compounded GLP-1s offered and my honest opinion about this provider.

This global initiative reframed obesity as a chronic, systemic disease rather than a mere risk factor

Using the correct U-100 syringe count is critical: one unit marking equals one unit of U-100 insulin

Taken together, these patterns suggest that GLP-1 adoption is not only transforming diabetes and obesity care but also influencing prescribing behavior and patient management across a broader set of comorbid markets

Philippines Glucagon Like Peptide-1 (GLP-1) Receptor Agonist Market is valued at around $34.6 Mn in 2022 and is projected to reach $65.2 Mn by 2030, exhibiting a CAGR of 8.23% during the forecast period 2023-2030.